Ads
related to: merck- AAV Reference Standards
Essential AAV Reference Standards
Full & Empty Capsids of 6 Serotypes
- Cell Therapy Production
Cell Therapy Manufacturing Services
From Clinical To Commercial
- GMP Retrovirus Services
cGMP-compliant & fully scalable
Viral vector manufacturing
- GMP QC Services
Viral Vector & Plasmid Assays
Quality, Sterility & Potency
- AAV Reference Standards
Search results
Merck (MRK) Ascends But Remains Behind Market: Some Facts to Note
Zacks via Yahoo Finance· 1 day agoMerck (MRK) closed the latest trading day at $129.45, indicating a +0.57% change from the previous...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Merck opens $195.7m expanded distribution centre in Germany
Pharmaceutical Technology via Yahoo Finance· 23 hours agoGerman science and technology company Merck KGaA has announced the opening of its expanded Life...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 3 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
How Merck Scientists Are Driving Next-Generation Cancer Research
Morningstar· 18 hours agoThis means, just as cancer isn't one disease, there cannot be just one way to treat all cancers. "We've witnessed dramatic progress in how we treat a wide range of cancers, and our work at & ...
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Simply Wall St. via Yahoo Finance· 6 days agoWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 3 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 4 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 4 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Morningstar· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive ...
